---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-002547"
form_type: "8-K"
ticker: "MLAB"
cik: "0000724004"
company_name: "MESA LABORATORIES INC /CO/"
filed_at: "2023-02-06T23:59:59+00:00"
generated_at: "2026-06-20T00:37:00.581683+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Mesa Labs Q3 revenue -1% to $54.3M; core organic growth 4.6%; net income up 122%

## Summary
- Revenues $54,287K, down 1% YoY; organic revenue decline 2.1% due to currency and other headwinds.
- Net income $451K ($0.08 diluted EPS) vs $203K in prior year; increase of 122%.
- Non-GAAP AOI excluding unusual items $12,856K (24% of revenue), down 7% YoY.
- Clinical Genomics revenues $15,585K, down 10% organic; core organic growth 3.3% ex-Sema4 would be 19%.
- SDC core organic growth 21.1%; Calibration Solutions impacted by supply chain constraints.

## SEC filing metadata
- accession: 0001437749-23-002547
- form_type: 8-K
- ticker: MLAB
- cik: 0000724004
- company_name: MESA LABORATORIES INC /CO/
- filed_at: 2023-02-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/724004/000143774923002547/0001437749-23-002547-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/724004/000143774923002547/mlab20230203_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-002547
- JSON: https://secwatch.observer/filing/0001437749-23-002547.json
- Plain text: https://secwatch.observer/filing/0001437749-23-002547.txt

## Key facts
- Earnings Releases
  MESA LABORATORIES INC /CO/ reported three and nine months ended December 31, 2022 results: revenue $54,287, net income $451, EPS $0.08 per diluted share.
  - Period: three and nine months ended December 31, 2022
  - Revenue: $54,287
  - Net income: $451
  - EPS: $0.08 per diluted share
  - Result: reported results
  source text: 3 was 4.6% ● Operating income increased 235% ● Non-GAAP adjusted operating income 1 excluding unusual items decreased 7% Executive Commentary (amounts in thousands) “Revenues of $54,287 in the quarter resulted in an organic revenues decline of 2.1% for the quarter, heavily influenced by currency headwinds across the company, as well as COVID headwinds and the
  evidence_url: https://www.sec.gov/Archives/edgar/data/724004/000143774923002547/0001437749-23-002547-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.